MetaADEDB 2.0 @ LMMD
Tolterodine Tartrate
(TWHNMSJGYKMTRB-KXYUELECSA-N)
Structure
SMILES
O[C@H]([C@H](C(=O)O)O)C(=O)O.Cc1ccc(c(c1)[C@@H](c1ccccc1)CCN(C(C)C)C(C)C)O
Molecular Formula:
C26H37NO7
Molecular Weight:
475.574
Log P:
3.2188
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
5
TPSA:
138.53
CAS Number(s):
124937-52-6; 209747-05-7
Synonym(s)
1.
Tolterodine Tartrate
2.
Detrol
3.
Detrol LA
4.
Detrusitol
5.
PHA-686464B
6.
Tolterodine
7.
Unidet
8.
Urotrol
9.
PHA 686464B
10.
PHA686464B
11.
Tartrate, Tolterodine
External Link(s)
MeSHD000068737
PubChem Compound139059519
443878
KEGGdr:D01148
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 530
Canada Vigilance: 44
Canada Vigilance
US FAERS
2ConstipationFAERS: 121
Canada Vigilance: 2
Canada Vigilance
US FAERS
3DizzinessFAERS: 76
Canada Vigilance: 3
Canada Vigilance
US FAERS
4Urinary RetentionFAERS: 68
Canada Vigilance: 7
15476515CTD
Canada Vigilance
US FAERS
5HeadacheFAERS: 63US FAERS
6Urinary IncontinenceFAERS: 53
Canada Vigilance: 5
15534031
15977961
20497930
CTD
Canada Vigilance
US FAERS
7DysuriaFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
8AmnesiaFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Abdominal PainFAERS: 37
Canada Vigilance: 2
Canada Vigilance
US FAERS
10MalaiseFAERS: 37US FAERS
11PainFAERS: 37
Canada Vigilance: 2
Canada Vigilance
US FAERS
12Drug effect incompleteFAERS: 36US FAERS
13Urinary tract infectionFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
14NauseaFAERS: 31US FAERS
15NocturiaFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
16FatigueFAERS: 29US FAERS
17Cerebrovascular accidentFAERS: 28US FAERS
18Memory impairmentFAERS: 27US FAERS
19PruritusFAERS: 27US FAERS
20DehydrationFAERS: 25US FAERS
21DyspepsiaFAERS: 24US FAERS
22HypersensitivityFAERS: 24
Canada Vigilance: 5
Canada Vigilance
US FAERS
23CystitisFAERS: 22
Canada Vigilance: 2
Canada Vigilance
US FAERS
24Feeling abnormalFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
25Incorrect dose administeredFAERS: 22US FAERS
26Myocardial InfarctionFAERS: 21US FAERS
27VomitingFAERS: 21US FAERS
28GlaucomaFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Product use issueFAERS: 18US FAERS
30nervous system disorderFAERS: 17US FAERS
31AnxietyFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Abdominal discomfortFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
33DementiaFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
34Diabetes MellitusFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
35Dry skinFAERS: 15US FAERS
36Weight decreasedFAERS: 15US FAERS
37Joint injuryFAERS: 14US FAERS
38PneumoniaFAERS: 14US FAERS
39Visual ImpairmentFAERS: 14US FAERS
40ArthritisFAERS: 13US FAERS
41CataractFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Bladder painFAERS: 12US FAERS
43DeafnessFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
44IncontinenceFAERS: 12US FAERS
45Oropharyngeal painFAERS: 12US FAERS
46SomnolenceFAERS: 12US FAERS
47UrticariaFAERS: 12US FAERS
48ArthropathyFAERS: 11US FAERS
49Back PainFAERS: 11US FAERS
50Chest PainFAERS: 11US FAERS
51NervousnessFAERS: 11US FAERS
52PalpitationsFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
53TremorFAERS: 11US FAERS
54Drug dose omissionFAERS: 10US FAERS
55FlushingFAERS: 10US FAERS
56NephrolithiasisFAERS: 10US FAERS
57AsthmaFAERS: 9US FAERS
58Atrial FibrillationFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
59Bladder prolapseFAERS: 9US FAERS
60DiscomfortFAERS: 9US FAERS
61FlatulenceFAERS: 9US FAERS
62Joint swellingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
63Macular degenerationFAERS: 9US FAERS
64No adverse eventFAERS: 9US FAERS
65Unevaluable eventFAERS: 9US FAERS
66AgitationFAERS: 8US FAERS
67BronchitisFAERS: 8US FAERS
68EructationFAERS: 8US FAERS
69IleusFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Medication ErrorFAERS: 8US FAERS
71Mental impairmentFAERS: 8US FAERS
72Post procedural complicationFAERS: 8US FAERS
73ThirstFAERS: 8US FAERS
74Angle Closure GlaucomaFAERS: 7US FAERS
75BlindnessFAERS: 7US FAERS
76Dental cariesFAERS: 7US FAERS
77Drug dispensing errorFAERS: 7US FAERS
78EpistaxisFAERS: 7US FAERS
79InfectionFAERS: 7US FAERS
80Intestinal ObstructionFAERS: 7US FAERS
81Stevens-Johnson SyndromeFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
82Wrong technique in drug usage processFAERS: 7US FAERS
83AstheniaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
84Bladder dysfunctionFAERS: 6US FAERS
85Bladder spasmFAERS: 6US FAERS
86Blood urine presentFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Circumstance or information capable of leading to medication errorFAERS: 6US FAERS
88DeliriumFAERS: 6US FAERS
89DisorientationFAERS: 6US FAERS
90DiverticulitisFAERS: 6US FAERS
91DysgeusiaFAERS: 6US FAERS
92Eye painFAERS: 6US FAERS
93Inappropriate schedule of drug administrationFAERS: 6US FAERS
94Intentional product misuseFAERS: 6US FAERS
95Multiple SclerosisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
96ParanoiaFAERS: 6US FAERS
97Product quality issueFAERS: 6US FAERS
98Product use in unapproved indicationFAERS: 6US FAERS
99StressFAERS: 6US FAERS
100TachycardiaFAERS: 6US FAERS
101Throat irritationFAERS: 6US FAERS
102VertigoFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
103AlopeciaFAERS: 5US FAERS
104Angina PectorisFAERS: 5US FAERS
105AnuriaFAERS: 5US FAERS
106ArthralgiaFAERS: 5US FAERS
107Burning sensationFAERS: 5US FAERS
108Cataract operationFAERS: 5US FAERS
109Chest discomfortFAERS: 5US FAERS
110CystopexyFAERS: 5US FAERS
111DiplopiaFAERS: 5US FAERS
112Drug effect delayedFAERS: 5US FAERS
113Drug level increasedFAERS: 5US FAERS
114Drug prescribing errorFAERS: 5US FAERS
115EnuresisFAERS: 5US FAERS
116ErythemaFAERS: 5US FAERS
117HypotensionFAERS: 5US FAERS
118HysterectomyFAERS: 5US FAERS
119Middle insomniaFAERS: 5US FAERS
120OsteoporosisFAERS: 5US FAERS
121Product substitution issueFAERS: 5US FAERS
122RetchingFAERS: 5US FAERS
123SwellingFAERS: 5US FAERS
124Therapeutic response unexpectedFAERS: 5US FAERS
125AngioedemaFAERS: 4US FAERS
126Blood cholesterol increasedFAERS: 4US FAERS
127Blood glucose increasedFAERS: 4US FAERS
128Blood potassium decreasedFAERS: 4US FAERS
129Blood pressure fluctuationFAERS: 4US FAERS
130Drug exposure during pregnancyFAERS: 4US FAERS
131Expired drug administeredFAERS: 4US FAERS
132Expired product administeredFAERS: 4US FAERS
133General physical health deteriorationFAERS: 4US FAERS
134HerniaFAERS: 4US FAERS
135HypothyroidismFAERS: 4US FAERS
136Intentional product use issueFAERS: 4US FAERS
137Limb injuryFAERS: 4US FAERS
138Musculoskeletal PainFAERS: 4US FAERS
139Musculoskeletal discomfortFAERS: 4US FAERS
140NasopharyngitisFAERS: 4US FAERS
141Pharmaceutical product complaintFAERS: 4US FAERS
142Pre-existing condition improvedFAERS: 4US FAERS
143Product physical issueFAERS: 4US FAERS
144Rheumatoid ArthritisFAERS: 4US FAERS
145SepsisFAERS: 4US FAERS
146Tethered Cord SyndromeFAERS: 4US FAERS
147Vulvovaginal drynessFAERS: 4US FAERS
148AbasiaFAERS: 3US FAERS
149AcneFAERS: 3US FAERS
150ArthrofibrosisFAERS: 3US FAERS
151Atrioventricular BlockFAERS: 3US FAERS
152Automatic bladderFAERS: 3US FAERS
153Benign Prostatic HyperplasiaFAERS: 3US FAERS
154Bladder NeoplasmFAERS: 3US FAERS
155Blood creatinine increasedFAERS: 3US FAERS
156BursitisFAERS: 3US FAERS
157CystoceleFAERS: 3US FAERS
158DisabilityFAERS: 3US FAERS
159Disease recurrenceFAERS: 3US FAERS
160Drug ineffective for unapproved indicationFAERS: 3US FAERS
161Emotional distressFAERS: 3US FAERS
162Endodontic procedureFAERS: 3US FAERS
163Erectile dysfunctionFAERS: 3US FAERS
164FrustrationFAERS: 3US FAERS
165HemiplegiaFAERS: 3US FAERS
166LethargyFAERS: 3US FAERS
167Limb discomfortFAERS: 3US FAERS
168Lip swellingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
169Maternal exposure during pregnancyFAERS: 3US FAERS
170Musculoskeletal chest painFAERS: 3US FAERS
171Myasthenia GravisFAERS: 3US FAERS
172OliguriaFAERS: 3US FAERS
173Poor quality drug administeredFAERS: 3US FAERS
174PregnancyFAERS: 3US FAERS
175RestlessnessFAERS: 3US FAERS
176SinusitisFAERS: 3US FAERS
177SyncopeFAERS: 3US FAERS
178Therapy non-responderFAERS: 3US FAERS
179ThrombosisFAERS: 3US FAERS
180Urine flow decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Accidental drug intake by childFAERS: 2US FAERS
182Activities of daily living impairedFAERS: 2US FAERS
183AgeusiaFAERS: 2US FAERS
184Anaphylactic shockFAERS: 2US FAERS
185AngerFAERS: 2US FAERS
186Ankle FractureFAERS: 2US FAERS
187Back disorderFAERS: 2US FAERS
188BedriddenFAERS: 2US FAERS
189Blood iron decreasedFAERS: 2US FAERS
190BradycardiaFAERS: 2US FAERS
191BradyphreniaFAERS: 2US FAERS
192Cartilage injuryFAERS: 2US FAERS
193CatatoniaFAERS: 2US FAERS
194ChillsFAERS: 2US FAERS
195CryingFAERS: 2US FAERS
196CystFAERS: 2US FAERS
197Depressed Level of ConsciousnessFAERS: 2US FAERS
198Device FailureFAERS: 2US FAERS
199DysphoniaFAERS: 2US FAERS
200Economic problemFAERS: 2US FAERS
201Emotional disorderFAERS: 2US FAERS
202Floppy iris syndromeFAERS: 2US FAERS
203Food AllergyFAERS: 2US FAERS
204GastritisFAERS: 2US FAERS
205House dust allergyFAERS: 2US FAERS
206Impaired gastric emptyingFAERS: 2US FAERS
207Impaired work abilityFAERS: 2US FAERS
208Increased upper airway secretionFAERS: 2US FAERS
209Infectious peritonitisFAERS: 2US FAERS
210InflammationFAERS: 2US FAERS
211Intervertebral Disc DegenerationFAERS: 2US FAERS
212Irritable Bowel SyndromeFAERS: 2US FAERS
213Lung AbscessFAERS: 2US FAERS
214Medical device complicationFAERS: 2US FAERS
215Muscle tightnessFAERS: 2US FAERS
216MyalgiaFAERS: 2US FAERS
217Mycotic allergyFAERS: 2US FAERS
218Pancreatic carcinomaFAERS: 2US FAERS
219ParaplegiaFAERS: 2US FAERS
220Product dose omissionFAERS: 2US FAERS
221Pulmonary FibrosisFAERS: 2US FAERS
222Radical prostatectomyFAERS: 2US FAERS
223Rash erythematousFAERS: 2US FAERS
224Reaction to drug excipientsFAERS: 2US FAERS
225Renal ColicFAERS: 2US FAERS
226Renal painFAERS: 2US FAERS
227Respiratory FailureFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
228Respiratory arrestFAERS: 2US FAERS
229Rotator cuff syndromeFAERS: 2US FAERS
230SclerodermaFAERS: 2US FAERS
231Skin UlcerFAERS: 2US FAERS
232Sodium retentionFAERS: 2US FAERS
233StrabismusFAERS: 2US FAERS
234Stress at workFAERS: 2US FAERS
235TinnitusFAERS: 2US FAERS
236Urinary hesitationFAERS: 2US FAERS
237Uterine CancerFAERS: 2US FAERS
238Uterine ProlapseFAERS: 2US FAERS
239Visual disturbanceFAERS: 2US FAERS
240XerosisFAERS: 2US FAERS
241prostatitisFAERS: 2US FAERS
242Accidental exposureFAERS: 1US FAERS
243Acute psychosisFAERS: 1US FAERS
244Adverse eventFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
245Alanine Aminotransferase IncreasedFAERS: 1US FAERS
246Alcohol interactionFAERS: 1US FAERS
247Amyotrophic Lateral SclerosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
248Anal discomfortFAERS: 1US FAERS
249Anticholinergic SyndromeFAERS: 1US FAERS
250AphasiaFAERS: 1US FAERS
251AphoniaFAERS: 1US FAERS
252Arthropod biteFAERS: 1US FAERS
253Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
254AsphyxiaFAERS: 1US FAERS
255AsthenopiaFAERS: 1US FAERS
256Bacteria urine identifiedFAERS: 1US FAERS
257Bipolar DisorderFAERS: 1US FAERS
258Bladder discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
259Blood cholesterol abnormalFAERS: 1US FAERS
260Blood count abnormalFAERS: 1US FAERS
261Blood glucose abnormalFAERS: 1US FAERS
262Blood sodium decreasedFAERS: 1US FAERS
263Blood sodium increasedFAERS: 1US FAERS
264Blood triglycerides increasedFAERS: 1US FAERS
265Blood urea increasedFAERS: 1US FAERS
266Bone contusionFAERS: 1US FAERS
267BruxismFAERS: 1US FAERS
268Cardiac FlutterFAERS: 1US FAERS
269Cardiac stress test abnormalFAERS: 1US FAERS
270CardiomegalyFAERS: 1US FAERS
271Cataract operation complicationFAERS: 1US FAERS
272Catheter placementFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
273Catheter related complicationFAERS: 1US FAERS
274CellulitisFAERS: 1US FAERS
275Cerebral hypoperfusionFAERS: 1US FAERS
276Cholecystitis infectiveFAERS: 1US FAERS
277ClumsinessFAERS: 1US FAERS
278Colonoscopy abnormalFAERS: 1US FAERS
279Completed SuicideFAERS: 1US FAERS
280Coronary Artery DiseaseFAERS: 1US FAERS
281Crystal urine presentFAERS: 1US FAERS
282Dark circles under eyesFAERS: 1US FAERS
283Depressed moodFAERS: 1US FAERS
284Diaphragmatic HerniaFAERS: 1US FAERS
285DiverticulumFAERS: 1US FAERS
286Drug DependenceFAERS: 1US FAERS
287Drug ToleranceFAERS: 1US FAERS
288Drug abuserFAERS: 1US FAERS
289Drug administration errorFAERS: 1US FAERS
290Drug exposure before pregnancyFAERS: 1US FAERS
291Drug exposure via breast milkFAERS: 1US FAERS
292Drug screen positiveFAERS: 1US FAERS
293Drug withdrawal syndromeFAERS: 1US FAERS
294EczemaFAERS: 1US FAERS
295Electrocardiogram abnormalFAERS: 1US FAERS
296Erythema MultiformeFAERS: 1US FAERS
297Escherichia infectionFAERS: 1US FAERS
298Essential HypertensionFAERS: 1US FAERS
299ExcoriationFAERS: 1US FAERS
300Eye InfectionFAERS: 1US FAERS
301Eye irritationFAERS: 1US FAERS
302Failure to ThriveFAERS: 1US FAERS
303Feeling ColdFAERS: 1US FAERS
304Food cravingFAERS: 1US FAERS
305Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
306GangreneFAERS: 1US FAERS
307Gastrointestinal PainFAERS: 1US FAERS
308General physical condition abnormalFAERS: 1US FAERS
309General symptomFAERS: 1US FAERS
310Glaucoma surgeryFAERS: 1US FAERS
311Global AmnesiaFAERS: 1US FAERS
312Grip strength decreasedFAERS: 1US FAERS
313Head discomfortFAERS: 1US FAERS
314Hearing aid userFAERS: 1US FAERS
315Heat ExhaustionFAERS: 1US FAERS
316HepatitisFAERS: 1US FAERS
317Hip surgeryFAERS: 1US FAERS
318HydrocephalusFAERS: 1US FAERS
319HyperchlorhydriaFAERS: 1US FAERS
320HyperkinesiaFAERS: 1US FAERS
321HypohidrosisFAERS: 1US FAERS
322HypokinesiaFAERS: 1US FAERS
323Impaired driving abilityFAERS: 1US FAERS
324Impaired self-careFAERS: 1US FAERS
325Incorrect storage of drugFAERS: 1US FAERS
326InfluenzaFAERS: 1US FAERS
327Initial insomniaFAERS: 1US FAERS
328Intentional drug misuseFAERS: 1US FAERS
329Intervertebral disc disorderFAERS: 1US FAERS
330IritisFAERS: 1US FAERS
331Joint Range of Motion DecreasedFAERS: 1US FAERS
332Joint sprainFAERS: 1US FAERS
333Keratoconjunctivitis SiccaFAERS: 1US FAERS
334LabyrinthitisFAERS: 1US FAERS
335LacerationFAERS: 1US FAERS
336LagophthalmosFAERS: 1US FAERS
337LaryngitisFAERS: 1US FAERS
338Living in residential institutionFAERS: 1US FAERS
339Lower respiratory tract infectionFAERS: 1US FAERS
340LymphadenopathyFAERS: 1US FAERS
341LymphomaFAERS: 1US FAERS
342MalnutritionFAERS: 1US FAERS
343MastectomyFAERS: 1US FAERS
344MastoiditisFAERS: 1US FAERS
345Medication residue presentFAERS: 1US FAERS
346MeningomyeloceleFAERS: 1US FAERS
347Meniscus injuryFAERS: 1US FAERS
348Mental status changesFAERS: 1US FAERS
349MetastasisFAERS: 1US FAERS
350MetrorrhagiaFAERS: 1US FAERS
351Micturition frequency decreasedFAERS: 1US FAERS
352Mouth BreathingFAERS: 1US FAERS
353Multiple MyelomaFAERS: 1US FAERS
354Multiple sclerosis relapseFAERS: 1US FAERS
355Myoclonic EpilepsyFAERS: 1US FAERS
356Nasal discomfortFAERS: 1US FAERS
357Neck PainFAERS: 1US FAERS
358NephrectomyFAERS: 1US FAERS
359Night sweatsFAERS: 1US FAERS
360No adverse effectFAERS: 1US FAERS
361ObesityFAERS: 1US FAERS
362ObstructionFAERS: 1US FAERS
363Ocular HypertensionFAERS: 1US FAERS
364Ocular discomfortFAERS: 1US FAERS
365Oral candidiasisFAERS: 1US FAERS
366OverdoseFAERS: 1US FAERS
367OverweightFAERS: 1US FAERS
368PallorFAERS: 1US FAERS
369PancreatitisFAERS: 1US FAERS
370ParotitisFAERS: 1US FAERS
371Peripheral arterial occlusive diseaseFAERS: 1US FAERS
372Personality ChangeFAERS: 1US FAERS
373Pharyngolaryngeal PainFAERS: 1US FAERS
374PolyneuropathyFAERS: 1US FAERS
375Post procedural infectionFAERS: 1US FAERS
376Post procedural swellingFAERS: 1US FAERS
377Postoperative constipationFAERS: 1US FAERS
378Postoperative thrombosisFAERS: 1US FAERS
379Prescribed overdoseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
380PresyncopeFAERS: 1US FAERS
381Product administered to patient of inappropriate ageFAERS: 1US FAERS
382Product comminglingFAERS: 1US FAERS
383Product tamperingFAERS: 1US FAERS
384Product use complaintFAERS: 1US FAERS
385Productive CoughFAERS: 1US FAERS
386ProstatectomyFAERS: 1US FAERS
387Protein total decreasedFAERS: 1US FAERS
388Psychiatric symptomFAERS: 1US FAERS
389Pulmonary EmbolismFAERS: 1US FAERS
390Pulmonary HypertensionFAERS: 1US FAERS
391Quality of life decreasedFAERS: 1US FAERS
392Rash scalyFAERS: 1US FAERS
393Renal cystFAERS: 1US FAERS
394Renal disorder in pregnancyFAERS: 1US FAERS
395Residual urine volume increasedFAERS: 1US FAERS
396Restless Legs SyndromeFAERS: 1US FAERS
397RhabdomyolysisFAERS: 1US FAERS
398RosaceaFAERS: 1US FAERS
399Salpingo-oophorectomyFAERS: 1US FAERS
400SciaticaFAERS: 1US FAERS
401Senile dementiaFAERS: 1US FAERS
402Sinus bradycardiaFAERS: 1US FAERS
403Sjogren's SyndromeFAERS: 1US FAERS
404Skin lesionFAERS: 1US FAERS
405Skin reactionFAERS: 1US FAERS
406Spinal column stenosisFAERS: 1US FAERS
407SpondylitisFAERS: 1US FAERS
408StomatitisFAERS: 1US FAERS
409Suicide attemptFAERS: 1US FAERS
410Suspected counterfeit productFAERS: 1US FAERS
411Systemic lupus erythematosus rashFAERS: 1US FAERS
412Tardive DyskinesiaFAERS: 1US FAERS
413Therapeutic procedureFAERS: 1US FAERS
414Therapeutic product effect incompleteFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
415Therapeutic response delayedFAERS: 1US FAERS
416Tooth ExtractionFAERS: 1US FAERS
417TransplantFAERS: 1US FAERS
418Traumatic Brain InjuryFAERS: 1US FAERS
419UnemploymentFAERS: 1US FAERS
420Unresponsive to stimuliFAERS: 1US FAERS
421Urge IncontinenceFAERS: 1US FAERS
422Urinary tract obstructionFAERS: 1US FAERS
423Urine output increasedFAERS: 1US FAERS
424VaginoplastyFAERS: 1US FAERS
425Vascular occlusionFAERS: 1US FAERS
426VasectomyFAERS: 1US FAERS
427Walking aid userFAERS: 1US FAERS
428Wound InfectionFAERS: 1US FAERS
429Wrong drug administeredFAERS: 1US FAERS
430muscle injuryFAERS: 1US FAERS
431Abdominal rigidityCanada Vigilance: 1Canada Vigilance
432Cognition Disorders17689620
18384584
CTD
433Confusion17689620CTD
434Hallucinations15534031CTD
435Loss of personal independence in daily activitiesCanada Vigilance: 1Canada Vigilance
436Peripheral swellingCanada Vigilance: 1Canada Vigilance
437Product administration errorCanada Vigilance: 1Canada Vigilance
438Therapeutic product effect decreasedCanada Vigilance: 2Canada Vigilance
439Uterovaginal prolapseCanada Vigilance: 1Canada Vigilance
440Xerostomia16471092CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.